Company Directory / Artificial Intelligence (AI)
PrivateFor profitArtificial Intelligence (AI)Cambridge, United States
1910 Genetics
1910 Genetics is a biotechnology company integrating AI, computation, and biological automation to improve drug development.
- Founded
- 2018 8 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $27M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
8 years old.
Reach
Website ranked #10,237,297 in the world for traffic, about 246 visits a month.
What it does
Artificial Intelligence (AI)BiotechnologyTherapeutics
Funding, as listed
$27M currency not stated
- Rounds4
- LatestGrant, Sept 2021
- Investors10, 3 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about 1910 Genetics, field by field. Contact details are held but never shown.
The company
- Name
- 1910 Genetics
- Type
- For profit
- Status
- Private
- Founded
- 2018
- Founders
- Jen Nwankwo
- Industry
- Artificial Intelligence (AI)
- Categories
- Artificial Intelligence (AI), Biotechnology, Therapeutics
Where
- City
- Cambridge
- Country
- United States
- Markets
- Greater Boston Area, East Coast, New England, Northeastern US
Size and reach
- Staff band
- 11-50
- Web traffic rank
- #10,237,297
- Monthly web visits
- 246
Funding, as listed
- Total
- 26,650,000 (currency not stated)
- Rounds
- 4
- Latest round
- Grant
- Latest round date
- Sept 2021
- Investors
- 10
- Lead investors
- 3
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
1910 Genetics may be growing as evidenced by their partnership with a major technology company to build the infrastructure layer for drug discovery and development using AI and high-performance computing. This collaboration indicates an expansion of operations and potentially an increase in the company's capabilities and market reach. The involvement of AI and high-performance computing in drug discovery is a significant qualitative growth indicator, suggesting that 1910 Genetics is advancing in a cutting-edge area of the biotechnology industry. Furthermore, such partnerships often come with financial investments, technical support, and shared expertise, which can contribute to the company's growth trajectory.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
Artificial Intelligence (AI) in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.